Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
halofuginone [Supplementary Concept]
Date introduced: January 1, 1975
1H-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl- [Supplementary Concept]
stereoselective antagonist of dopamine receptor
Date introduced: April 18, 1985
2-((4-bromo-2-fluorophenyl)methyl)-6-fluorospiro(isoquinoline-4(1H),3'-pyrrolidine)-1,2',3,5'(2H)-tetrone [Supplementary Concept]
RN refers to (+-)-stereoisomer; structure given in first source
Date introduced: August 8, 1994
4-halobenzoate-CoA ligase [Supplementary Concept]
involved in conversion of 4-chlorobenzoate to 4-hydroxybenzoate by Pseudomonas sp. CBS3; 115 kDa; acts on 4-chloro-, 4-bromo-, 4-iodobenzoate most effectively; 16 N-terminal amino acid sequence determined, with 3 questions, in first source
Date introduced: December 4, 1992
SB-706375 [Supplementary Concept]
nonpeptidic urotensin-II receptor antagonist; structure in first source
Date introduced: October 27, 2005
etravirine [Supplementary Concept]
HIV-1 reverse transriptase inhibitor
Date introduced: April 17, 2002
technetium Tc 99m mebrofenin [Supplementary Concept]
hepatobiliary radiopharmaceutical
Date introduced: July 7, 1982
1-(4'-bromo-4-biphenylyl)-1-(4-chlorophenyl)-3-dimethylaminoprop-1-ene [Supplementary Concept]
RN given refers to (E)-isomer; structure given in first source
Date introduced: May 24, 1982
3-(4-bromo-3-oxobutanesulfonyl)-1-propionic acid 4-nitrophenyl ester [Supplementary Concept]
Date introduced: February 17, 1981
4-bromohomoibotenic acid [Supplementary Concept]
structure given in first source; RN given refers to (R)-isomer; RN for cpd without isomeric designation not available 11/89
Date introduced: April 4, 1980
2-((5-bromo-4-((4-bromonaphth-1-yl)methyl)-4H-1,2,4-triazol-3-yl)thio)acetic acid [Supplementary Concept]
a uric acid transporter 1 (URAT1) inhibitor; structure in first source
Date introduced: August 27, 2017
2-((5-bromo-4-((4-n-propylnaphth-1-yl)methyl)-4H-1,2,4-triazol-3-yl)thio)acetic acid [Supplementary Concept]
3-hydroxy-7-bromo-5-(ortho-chlorophenyl)-1,2-dihydro-3H-1,4-benzdiazepin-2-one [Supplementary Concept]
a tranquilizer; structure in first source
Date introduced: April 29, 2012
3-(4-bromobenzyl)-5-(1H-indol-3-yl-methylene)-2-thioxoimidazolidin-4-one [Supplementary Concept]
has anti-inflammatory and antinociceptive activities
Date introduced: April 26, 2012
SWR 104SA [Supplementary Concept]
structure given in first source
Date introduced: January 30, 1997
5-bromo-4-chloro-3-indolyl beta-galactoside [Supplementary Concept]
enzyme substrate for beta-galactosidase
Date introduced: May 7, 1985
N-(3-(5-(4-bromo-2-fluorophenylamino)-3-cyclopropyl-8-methyl-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido(2,3-d)pyrimidin-1-yl)phenyl)methanesulfonamide [Supplementary Concept]
a protein kinase inhibitor and antineoplastic agent; structure in first source
Date introduced: November 9, 2010
NS-3728 [Supplementary Concept]
di-aryl urea compound that inhibits anion channels
Date introduced: March 7, 2007
3-(2-(3-carboxy-4-bromo-5,6,7,8-tetrahydronaphthyl)ethyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol [Supplementary Concept]
structure in first source
Date introduced: March 14, 2001
3-bromo-2-hydroxy-N-(3,4-dimethyl-5-isoxazolyl)-1,4-naphthoquinon-4-imine [Supplementary Concept]
Date introduced: April 14, 1995